Wow
Dxb still in phase 3
Trial results in 2025 ( 2nd interim results )
Im confident Per will secure a Big Pharma or two while we are in Phase 2b
because if the 6 month readout is successful
the Partner will carry on funding the next 6 months with the 45 boys
But
If the readout is spectacular Per will go to the FDA for accelerated approval and commercialisation ..Big Pharma will have to pay a great deal more..
DXB : FSGS market is >200,000 @US $120,000 per annum..
Note
Per has a much bigger market with multiple indications
$$
Not rubbishing DXB or PYC
just trying to get a handle what PER will be worth in Time
IMO: >$5
WowDxb still in phase 3Trial results in 2025 ( 2nd interim...
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.9¢ |
Change
-0.046(34.1%) |
Mkt cap ! $80.23M | |||
| Open | High | Low | Value | Volume |
| 8.7¢ | 9.0¢ | 8.6¢ | $2.082M | 23.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 250808 | 8.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.9¢ | 312804 | 3 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |